We are proud to announce that the Efferon LPS hemoadsorption device has received official authorization in Thailand. This makes Thailand the 40th country where Efferon is available!

Together with our partner, NorrDia AB, we are committed to supporting and developing new regions to achieve sustainable, long-term growth and bring our innovative therapies to patients in need.

Efferon LPS is a next-generation extracorporeal blood adsorber designed to remove endotoxin and inflammatory mediators. The device is manufactured in the European Union and holds a CE certificate in accordance with the MDR, reflecting compliance with current European standards.